Changeflow GovPing Healthcare & Life Sciences Medicament Delivery Device Patent Application
Routine Notice Added Final

Medicament Delivery Device Patent Application

Favicon for changeflow.com USPTO Patent Applications - Medical Devices (A61M)
Published
Detected
Email

Summary

The USPTO has published a new patent application, US20260083914A1, related to a medicament delivery device and its subassembly. The application was filed on August 29, 2023, by inventors Daniel Säll, Tai-Fu Wang, and Chun-Hsien Huang.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has published patent application US20260083914A1, detailing a medicament delivery device, specifically a subassembly for devices like autoinjectors. The application was filed on August 29, 2023, by inventors Daniel Säll, Tai-Fu Wang, and Chun-Hsien Huang, and includes various CPC classifications related to drug delivery mechanisms.

This publication represents a new patent application and does not impose immediate regulatory obligations. However, it is relevant for companies in the pharmaceutical and medical device sectors involved in the development or manufacturing of drug delivery systems, as it may indicate future technological advancements or potential intellectual property considerations.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

A medicament delivery device and a subassembly of a medicament delivery device

Application US20260083914A1 Kind: A1 Mar 26, 2026

Inventors

Daniel Säll, Tai-Fu Wang, Chun-Hsien Huang

Abstract

The present disclosure generally relates to medicament delivery devices such as autoinjectors, and particularly concerns a subassembly of a medicament delivery device.

CPC Classifications

A61M 5/20 A61M 5/31566 A61M 5/31586 A61M 5/3202 A61M 2005/2026 A61M 2205/332 A61M 2205/44 A61M 2205/502 A61M 2205/581

Filing Date

2023-08-29

Application No.

19110476

View original document →

Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
August 29th, 2023
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260083914A1

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Drug Labeling Medical Device Manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11
Topics
Medical Devices Intellectual Property

Get alerts for this source

We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!